James Nisco

CIK: 0002020260

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)9 (75.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

LSTA

LISATA THERAPEUTICS, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (12 total)

LSTA
LISATA THERAPEUTICS, INC.
Jan 9, 2026
Award(A)
Direct
15K shares-
LSTA
LISATA THERAPEUTICS, INC.
Jan 9, 2026
Tax Payment(F)
Direct
2.1K shares at avg. $1.97$4K
LSTA
LISATA THERAPEUTICS, INC.
Jan 9, 2026
Tax Payment(F)
Direct
2.1K shares at avg. $1.97$4K
LSTA
LISATA THERAPEUTICS, INC.
Jan 9, 2026
Tax Payment(F)
Direct
1.1K shares at avg. $1.97$2K
LSTA
LISATA THERAPEUTICS, INC.
Jan 9, 2026
Tax Payment(F)
Direct
781 shares at avg. $1.97$2K
LSTA
LISATA THERAPEUTICS, INC.
Jan 10, 2025
Tax Payment(F)
Direct
416 shares at avg. $3.73$2K
LSTA
LISATA THERAPEUTICS, INC.
Jan 9, 2025
Award(A)
Direct
15K shares-
LSTA
LISATA THERAPEUTICS, INC.
Jan 9, 2025
Tax Payment(F)
Direct
2.1K shares at avg. $3.80$8K
LSTA
LISATA THERAPEUTICS, INC.
Jan 9, 2025
Tax Payment(F)
Direct
1.1K shares at avg. $3.80$4K
LSTA
LISATA THERAPEUTICS, INC.
Jan 9, 2025
Tax Payment(F)
Direct
781 shares at avg. $3.80$3K
LSTA
LISATA THERAPEUTICS, INC.
Oct 1, 2024
Tax Payment(F)
Direct
1.7K shares at avg. $2.93$5K
LSTA
LISATA THERAPEUTICS, INC.
Oct 1, 2024
Award(A)
Direct
3.3K shares at avg. $2.93$10K

		Type	Shares	Price		Ownership
Jan 9, 2026	LSTA LISATA THERAPEUTICS, INC.	Award(A)	15,000	-	$0	Direct
Jan 9, 2026	LSTA LISATA THERAPEUTICS, INC.	Tax Payment(F)	2,131	$1.97	$4,198	Direct
Jan 9, 2026	LSTA LISATA THERAPEUTICS, INC.	Tax Payment(F)	2,131	$1.97	$4,198	Direct
Jan 9, 2026	LSTA LISATA THERAPEUTICS, INC.	Tax Payment(F)	1,137	$1.97	$2,240	Direct
Jan 9, 2026	LSTA LISATA THERAPEUTICS, INC.	Tax Payment(F)	781	$1.97	$1,539	Direct
Jan 10, 2025	LSTA LISATA THERAPEUTICS, INC.	Tax Payment(F)	416	$3.73	$1,552	Direct
Jan 9, 2025	LSTA LISATA THERAPEUTICS, INC.	Award(A)	15,000	-	$0	Direct
Jan 9, 2025	LSTA LISATA THERAPEUTICS, INC.	Tax Payment(F)	2,131	$3.80	$8,098	Direct
Jan 9, 2025	LSTA LISATA THERAPEUTICS, INC.	Tax Payment(F)	1,137	$3.80	$4,321	Direct
Jan 9, 2025	LSTA LISATA THERAPEUTICS, INC.	Tax Payment(F)	781	$3.80	$2,968	Direct
Oct 1, 2024	LSTA LISATA THERAPEUTICS, INC.	Tax Payment(F)	1,701	$2.93	$4,984	Direct
Oct 1, 2024	LSTA LISATA THERAPEUTICS, INC.	Award(A)	3,300	$2.93	$9,669	Direct

1-12 of 12 transactions

About Nisco James

Nisco James (SEC CIK 0002020260) files insider reports with the SEC as SVP, Fin/Treas, Chief Actg Off of LISATA THERAPEUTICS, INC. (LSTA).

Signal8 holds 3 ownership filings by Nisco James, all Form 4s, filed between Oct 2, 2024 and Jan 13, 2026. Those filings report 12 transactions, from Oct 1, 2024 to Jan 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Nisco James's filings is in BASKING RIDGE, NJ.

Recent filings by Nisco James

Jan 9, 2026: Grant or award of LSTA shares (Form 4, code A).
Jan 9, 2026: Tax withholdings of LSTA shares (4 lines, Form 4, code F).
Jan 10, 2025: Tax withholding of LSTA shares (Form 4, code F).
Jan 9, 2025: Grant or award of LSTA shares (Form 4, code A).
Jan 9, 2025: Tax withholdings of LSTA shares (3 lines, Form 4, code F).

Other insiders filing for LISATA THERAPEUTICS, INC. (LSTA)

Farrow Jeffrey S, Director
LOVE TED W, Director
Lehrer-Graiwer Joshua, President & COO
Mazzo David J, President & CEO
Imam Tariq, SVP, Bus Dev, General Counsel
Buck Kristen K, EVP, R&D and CMO

How to read Form 4 transaction codes